# Paysign, Inc.: financial statements, quarterly

PAYS · Nasdaq · CIK 1496443 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pays.md) · [Financials](/companies/pays/financials.md) · [Filings](/companies/pays/filings.md) · [Insiders](/companies/pays/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pays/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [12.4](/filings/0001683168-24-007637.md) | [13.7 d](/filings/0001683168-25-001888.md) | [13.2](/filings/0001683168-25-003316.md) | [14.3](/filings/0001683168-25-005680.md) | [15.3](/filings/0001683168-25-008281.md) | [15.6 d](/filings/0001683168-26-002180.md) | [18.6](/filings/0001683168-26-003762.md) | [19.1](/filings/0001683168-26-006021.md) | [21.6](/filings/0001683168-25-008281.md) | [22.8 d](/filings/0001683168-26-002180.md) | [28.0](/filings/0001683168-26-003762.md) | [28.3](/filings/0001683168-26-006021.md) |
| Cost of revenue | $m | [6.1](/filings/0001683168-24-007637.md) | [6.5 d](/filings/0001683168-25-001888.md) | [6.3](/filings/0001683168-25-003316.md) | [6.7](/filings/0001683168-25-005680.md) | [6.8](/filings/0001683168-25-008281.md) | [6.4 d](/filings/0001683168-26-002180.md) | [6.9](/filings/0001683168-26-003762.md) | [7.3](/filings/0001683168-26-006021.md) | [9.4](/filings/0001683168-25-008281.md) | [9.6 d](/filings/0001683168-26-002180.md) | [9.8](/filings/0001683168-26-003762.md) | [10.4](/filings/0001683168-26-006021.md) |
| Gross profit | $m | [6.3](/filings/0001683168-24-007637.md) | [7.1 d](/filings/0001683168-25-001888.md) | [6.9](/filings/0001683168-25-003316.md) | [7.6](/filings/0001683168-25-005680.md) | [8.5](/filings/0001683168-25-008281.md) | [9.2 d](/filings/0001683168-26-002180.md) | [11.7](/filings/0001683168-26-003762.md) | [11.8](/filings/0001683168-26-006021.md) | [12.2](/filings/0001683168-25-008281.md) | [13.1 d](/filings/0001683168-26-002180.md) | [18.2](/filings/0001683168-26-003762.md) | [17.9](/filings/0001683168-26-006021.md) |
| Selling, general and administrative | $m | [4.7](/filings/0001683168-24-007637.md) | [5.3 d](/filings/0001683168-25-001888.md) | [5.9](/filings/0001683168-25-003316.md) | [6.0](/filings/0001683168-25-005680.md) | [6.2](/filings/0001683168-25-008281.md) | [7.0 d](/filings/0001683168-26-002180.md) | [7.4](/filings/0001683168-26-003762.md) | [8.2](/filings/0001683168-26-006021.md) | [8.4](/filings/0001683168-25-008281.md) | [9.1 d](/filings/0001683168-26-002180.md) | [8.9](/filings/0001683168-26-003762.md) | [8.5](/filings/0001683168-26-006021.md) |
| Operating income | $m | [0.6](/filings/0001683168-24-007637.md) | [0.6 d](/filings/0001683168-25-001888.md) | [(0.3)](/filings/0001683168-25-003316.md) | [0.1](/filings/0001683168-25-005680.md) | [0.7](/filings/0001683168-25-008281.md) | [0.5 d](/filings/0001683168-26-002180.md) | [2.5](/filings/0001683168-26-003762.md) | [1.4](/filings/0001683168-26-006021.md) | [1.6](/filings/0001683168-25-008281.md) | [1.9 d](/filings/0001683168-26-002180.md) | [6.7](/filings/0001683168-26-003762.md) | [7.0](/filings/0001683168-26-006021.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.1](/filings/0001683168-24-007637.md) | [(4.3) d](/filings/0001683168-25-001888.md) | [0.2](/filings/0001683168-25-003316.md) | [0.2](/filings/0001683168-25-005680.md) | [0.1](/filings/0001683168-25-008281.md) | [(0.1) d](/filings/0001683168-26-002180.md) | [0.7](/filings/0001683168-26-003762.md) | [0.7](/filings/0001683168-26-006021.md) | [0.0](/filings/0001683168-25-008281.md) | [1.1 d](/filings/0001683168-26-002180.md) | [2.0](/filings/0001683168-26-003762.md) | [1.1](/filings/0001683168-26-006021.md) |
| Net income | $m | [1.1](/filings/0001683168-24-007637.md) | [5.6 d](/filings/0001683168-25-001888.md) | [0.3](/filings/0001683168-25-008281.md) | [0.7](/filings/0001683168-25-008281.md) | [1.4](/filings/0001683168-25-008281.md) | [1.4 d](/filings/0001683168-26-002180.md) | [2.6](/filings/0001683168-26-006021.md) | [1.4](/filings/0001683168-26-006021.md) | [2.2](/filings/0001683168-25-008281.md) | [1.4 d](/filings/0001683168-26-002180.md) | [5.4](/filings/0001683168-26-006021.md) | [6.8](/filings/0001683168-26-006021.md) |
| Diluted EPS | $ per share | [0.02](/filings/0001683168-24-007637.md) | not reported | [0.01](/filings/0001683168-25-003316.md) | [0.01](/filings/0001683168-25-005680.md) | [0.03](/filings/0001683168-25-008281.md) | not reported | [0.05](/filings/0001683168-26-003762.md) | [0.02](/filings/0001683168-26-006021.md) | [0.04](/filings/0001683168-25-008281.md) | not reported | [0.09](/filings/0001683168-26-003762.md) | [0.11](/filings/0001683168-26-006021.md) |
| Basic EPS | $ per share | [0.02](/filings/0001683168-24-007637.md) | not reported | [0.01](/filings/0001683168-25-003316.md) | [0.01](/filings/0001683168-25-005680.md) | [0.03](/filings/0001683168-25-008281.md) | not reported | [0.05](/filings/0001683168-26-003762.md) | [0.03](/filings/0001683168-26-006021.md) | [0.04](/filings/0001683168-25-008281.md) | not reported | [0.10](/filings/0001683168-26-003762.md) | [0.12](/filings/0001683168-26-006021.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [9.9](/filings/0001683168-24-007637.md) | [17.0](/filings/0001683168-25-001888.md) | [7.0](/filings/0001683168-25-003316.md) | [31.3](/filings/0001683168-25-005680.md) | [10.3](/filings/0001683168-25-008281.md) | [10.8](/filings/0001683168-26-002180.md) | [6.8](/filings/0001683168-26-003762.md) | [11.8](/filings/0001683168-26-006021.md) | [7.5](/filings/0001683168-25-008281.md) | [21.1](/filings/0001683168-26-006021.md) | [20.5](/filings/0001683168-26-003762.md) | [27.4](/filings/0001683168-26-006021.md) |
| Current assets | $m | [98.9](/filings/0001683168-23-007686.md) | [129](/filings/0001683168-25-001888.md) | [155](/filings/0001683168-24-003066.md) | [163](/filings/0001683168-24-005193.md) | [147](/filings/0001683168-24-007637.md) | [159](/filings/0001683168-26-002180.md) | [167](/filings/0001683168-25-003316.md) | [159](/filings/0001683168-25-005680.md) | [171](/filings/0001683168-25-008281.md) | [240](/filings/0001683168-26-006021.md) | [277](/filings/0001683168-26-003762.md) | [283](/filings/0001683168-26-006021.md) |
| Total assets | $m | [111](/filings/0001683168-23-007686.md) | [147](/filings/0001683168-25-001888.md) | [173](/filings/0001683168-24-003066.md) | [182](/filings/0001683168-24-005193.md) | [167](/filings/0001683168-24-007637.md) | [179](/filings/0001683168-26-002180.md) | [205](/filings/0001683168-25-003316.md) | [194](/filings/0001683168-25-005680.md) | [210](/filings/0001683168-25-008281.md) | [276](/filings/0001683168-26-006021.md) | [313](/filings/0001683168-26-003762.md) | [317](/filings/0001683168-26-006021.md) |
| Current liabilities | $m | [90.0](/filings/0001683168-23-007686.md) | [119](/filings/0001683168-25-001888.md) | [145](/filings/0001683168-24-003066.md) | [153](/filings/0001683168-24-005193.md) | [136](/filings/0001683168-24-007637.md) | [146](/filings/0001683168-26-002180.md) | [156](/filings/0001683168-25-003316.md) | [143](/filings/0001683168-25-005680.md) | [152](/filings/0001683168-25-008281.md) | [216](/filings/0001683168-26-006021.md) | [248](/filings/0001683168-26-003762.md) | [248](/filings/0001683168-26-006021.md) |
| Total liabilities | $m | [93.0](/filings/0001683168-23-007686.md) | [122](/filings/0001683168-25-001888.md) | [148](/filings/0001683168-24-003066.md) | [155](/filings/0001683168-24-005193.md) | [138](/filings/0001683168-24-007637.md) | [149](/filings/0001683168-26-002180.md) | [166](/filings/0001683168-25-003316.md) | [152](/filings/0001683168-25-005680.md) | [164](/filings/0001683168-25-008281.md) | [228](/filings/0001683168-26-006021.md) | [258](/filings/0001683168-26-003762.md) | [257](/filings/0001683168-26-006021.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001683168-26-002180.md) | [7.8](/filings/0001683168-25-003316.md) | [6.1](/filings/0001683168-25-005680.md) | [6.1](/filings/0001683168-25-008281.md) | [6.1](/filings/0001683168-26-006021.md) | [4.6](/filings/0001683168-26-003762.md) | [3.6](/filings/0001683168-26-006021.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001683168-26-002180.md) | [2.0](/filings/0001683168-25-003316.md) | [1.6](/filings/0001683168-25-005680.md) | [1.7](/filings/0001683168-25-008281.md) | [1.9](/filings/0001683168-26-006021.md) | [1.6](/filings/0001683168-26-003762.md) | [1.7](/filings/0001683168-26-006021.md) |
| Shareholders' equity | $m | [18.2](/filings/0001683168-24-007637.md) | [24.5](/filings/0001683168-26-002180.md) | [25.5](/filings/0001683168-25-008281.md) | [26.9](/filings/0001683168-25-008281.md) | [28.5](/filings/0001683168-25-008281.md) | [30.4](/filings/0001683168-26-006021.md) | [39.3](/filings/0001683168-26-006021.md) | [42.2](/filings/0001683168-26-006021.md) | [45.8](/filings/0001683168-25-008281.md) | [48.5](/filings/0001683168-26-006021.md) | [55.0](/filings/0001683168-26-006021.md) | [60.2](/filings/0001683168-26-006021.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [4.0 d](/filings/0001683168-24-007637.md) | [23.4 d](/filings/0001683168-25-001888.md) | [8.2](/filings/0001683168-25-003316.md) | [20.6 d](/filings/0001683168-25-005680.md) | [(20.2) d](/filings/0001683168-25-008281.md) | [14.3 d](/filings/0001683168-26-002180.md) | [(6.0)](/filings/0001683168-26-003762.md) | [3.6 d](/filings/0001683168-26-006021.md) | [6.8 d](/filings/0001683168-25-008281.md) | [48.1 d](/filings/0001683168-26-002180.md) | [18.8](/filings/0001683168-26-003762.md) | [1.3 d](/filings/0001683168-26-006021.md) |
| Capital expenditure | $m | [0.1 d](/filings/0001683168-24-007637.md) | [0.0 d](/filings/0001683168-25-001888.md) | [0.1](/filings/0001683168-25-003316.md) | [0.1 d](/filings/0001683168-25-005680.md) | [0.1 d](/filings/0001683168-25-008281.md) | [0.1 d](/filings/0001683168-26-002180.md) | [0.1](/filings/0001683168-26-003762.md) | [0.1 d](/filings/0001683168-26-006021.md) | [0.5 d](/filings/0001683168-25-008281.md) | [0.6 d](/filings/0001683168-26-002180.md) | [0.3](/filings/0001683168-26-003762.md) | [0.1 d](/filings/0001683168-26-006021.md) |
| Share repurchases | $m | [0.2 d](/filings/0001683168-24-007637.md) | [0.0 d](/filings/0001683168-25-001888.md) | [0.0](/filings/0001683168-25-003316.md) | [0.0 d](/filings/0001683168-25-005680.md) | [0.4 d](/filings/0001683168-25-008281.md) | [0.1 d](/filings/0001683168-26-002180.md) | [0.4](/filings/0001683168-26-003762.md) | [0.0 d](/filings/0001683168-26-006021.md) | [0.0 d](/filings/0001683168-25-008281.md) | [0.0 d](/filings/0001683168-26-002180.md) | [0.2](/filings/0001683168-26-003762.md) | [(0.2) d](/filings/0001683168-26-006021.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [53.4](/filings/0001683168-23-007686.md) | [52.4](/filings/0001683168-24-003066.md) | [52.3](/filings/0001683168-24-005193.md) | [53.5](/filings/0001683168-24-007637.md) | [54.8](/filings/0001683168-25-003316.md) | [55.9](/filings/0001683168-25-005680.md) | [56.1](/filings/0001683168-25-008281.md) | [55.1](/filings/0001683168-26-003762.md) | [57.9](/filings/0001683168-26-006021.md) | [61.8](/filings/0001683168-25-008281.md) | [61.0](/filings/0001683168-26-003762.md) | [62.0](/filings/0001683168-26-006021.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 56,462,156 at 2026-07-30, from the cover of the [10-Q filed 2026-08-06](/filings/0001683168-26-006021.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.